Search - tctmd.com

Displaying 601 - 620 of 940

Sort: Relevancy | Date

Presentation TCT 2014

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Presenter: Ajay J. Kirtane, David Taggart, David J. Maron

September 15, 2014

Presentation TCT 2014

Forget Hybrid Do the Whole Thing Robotically!

Presenter: Ajay J. Kirtane, David Taggart, Michael DECEASED J. Davidson

September 15, 2014

Presentation TCT 2014

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Presenter: Ajay J. Kirtane, David Taggart

September 15, 2014

Presentation TCT 2014

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

Presenter: Ajay J. Kirtane, David Taggart, Molly Szerlip

September 15, 2014

Presentation TCT 2014

Understanding Anatomy-Device Interactions of Different Bifurcation Stent Techniques: Insights From the Visible Heart Lab

Presenter: Francesco Burzotta, Paul A. Iaizzo, Ajay J. Kirtane, Azeem Latib

September 15, 2014

Presentation TCT 2014

A Compelling and Controversial Case for Complex PCI in the Modern Era

Presenter: E. Magnus Ohman, Gregg W. Stone, Stefan K. James, Ajay J. Kirtane

September 15, 2014

Presentation TCT 2014

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Frederick Feit

September 14, 2014

Presentation TCT 2014

Antiplatelet Management Before Non-cardiac Surgery

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Davide Capodanno

September 14, 2014

Presentation TCT 2014

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Freek W.A. Verheugt

September 14, 2014

Presentation TCT 2014

Featured Lecture: First Presentation of the PLATO Primary PCI Subgroup

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Philippe Gabriel Steg

September 14, 2014

Presentation TCT 2014

How Might Genetic and Platelet Function Testing Be Rationally Used TODAY?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Paul A. Gurbel

September 14, 2014

Presentation TCT 2014

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price

September 14, 2014

Presentation TCT 2014

De-escalating Antiplatelet Treatment in ACS Patients: New Concepts and Upcoming Studies

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Anthony A. Bavry

September 14, 2014

Presentation TCT 2014

TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study

Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Not So Fast: Only a Hypothesis has Been Generated!

Presenter: Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Renal Denervation: Boom or Bust?

Presenter: Martina Kelly Speight, Sarah Clarke, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

How Does the Data Guide Us? Case #1

Presenter: Julie Logan, Marian C. Hawkey, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Mahmoud Hashemian, Ajay J. Kirtane, Mohammad Ali Ostovan, Hrvoje Pintaric, Josko Bulum

September 14, 2014

Advertisement

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Forget Hybrid Do the Whole Thing Robotically!

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

Understanding Anatomy-Device Interactions of Different Bifurcation Stent Techniques: Insights From the Visible Heart Lab

A Compelling and Controversial Case for Complex PCI in the Modern Era

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

Antiplatelet Management Before Non-cardiac Surgery

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Featured Lecture: First Presentation of the PLATO Primary PCI Subgroup

How Might Genetic and Platelet Function Testing Be Rationally Used TODAY?

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

De-escalating Antiplatelet Treatment in ACS Patients: New Concepts and Upcoming Studies

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study

Updates and Status of the Boston Scientific Vessix Program

Not So Fast: Only a Hypothesis has Been Generated!

Renal Denervation: Boom or Bust?

How Does the Data Guide Us? Case #1

Consensus and Take-home Messages

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content